Breaking News

CARsgen to Expand Commercial Manufacturing Base in Shanghai

Signs Strategic Cooperation Agreements with Shanghai Jingong Enterprise.

Author Image

By: Charlie Sternberg

Associate Editor

CARsgen Therapeutics Holdings Limited, a company focused on developing innovative CAR T-cell therapies, has signed Strategic Cooperation Agreements with Shanghai Jingong Enterprise, which is a key platform enterprise in the Bay Area High-Tech Zone of Jinshan District, Shanghai. With a total investment amount not exceeding $53.6 million, the Company will establish an advanced commercial manufacturing base for CAR T-cell products in Jinshan District, Shanghai. This move closely aligns with t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters